| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |